
Latest
Boswellia vs. Celecoxib for Osteoarthritis: What a 24-Week Equivalence Trial Actually Showed
A pharma-led comparison of Boswellia serrata and celecoxib (Celebrex) for knee osteoarthritis, with an honest reading of the 24-week Chopra equivalence trial and the 5-LOX vs. COX-2 mechanism distinction.







